NYSE:ABBV

ABBVIE INC.

Stock

USD

Last Close

195.18

30/08 20:00

Market Cap

346.75B

Beta: 0.55

Volume Today

2.13M

Avg: 6.07M

PE Ratio

46.58

PFCF: 12.27

Dividend Yield

3.48%

Payout:159.95%

Overview Analysis Financials Filings people Ownership API Chart Data

locale
United States
market
STOCKS
industry
Drug Manufacturers - General
website
www.abbvieinvestor.com
ipo date
Jan 02, 2013

AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics (including Botox).

NYSE:ABBV

ABBVIE INC.

Last Close

195.18

30/08 20:00

Market Cap

346.75B

Beta: 0.55

Volume Today

2.13M

Avg: 6.07M

PE Ratio

46.58

PFCF: 12.27

Dividend Yield

3.48%

Payout:159.95%

locale

market

industry

website

ipo date

peer of

Earnings

Earnings per Share (Estimate*)

Revenue (Estimate*)

Metrics